Oxford scientists believe they could have breakthrough on Covid-19 vaccine – Telegraph

Oxford scientists believe they could have a breakthrough on Covid-19 vaccine, which is reported in the Telegraph today. 

Key notes

  • The clinical trials have so far been successful, the Telegraph understands.
  • Researchers have shown that antibodies produced against sections of a genetic material called spike protein, usually found on the surface of the coronavirus, after infection are able to kill the virus when tested in the laboratory.  
  • They want the human body to recognise and develop antibodies to the protein that would stop the virus from entering human cells.
  • Trials suggest that not only is this happening but also that the body is developing a crucial T-cell response as well, which is deemed crucial in the defence against coronavirus.

When will it be available?

The article states that AstraZeneca is on track to begin rolling out up to two billion doses of a coronavirus vaccine in September if ongoing trials continue to prove successful.

What is the next step?

As the level of coronavirus in the UK subsided, scientists began trialling the drug in hospitals, where it was likely to be more prevalent.

They have also enrolled 5,000 volunteers in Brazil and others in South Africa.

Developers are expected to report their Phase I study results - which would show whether it is safe and whether or not it induces an immune response - within the next fortnight.

Market implications

"Bring it on!", say the bulls. 

Information on these pages contains forward-looking statements that involve risks and uncertainties. Markets and instruments profiled on this page are for informational purposes only and should not in any way come across as a recommendation to buy or sell in these assets. You should do your own thorough research before making any investment decisions. FXStreet does not in any way guarantee that this information is free from mistakes, errors, or material misstatements. It also does not guarantee that this information is of a timely nature. Investing in Open Markets involves a great deal of risk, including the loss of all or a portion of your investment, as well as emotional distress. All risks, losses and costs associated with investing, including total loss of principal, are your responsibility. The views and opinions expressed in this article are those of the authors and do not necessarily reflect the official policy or position of FXStreet nor its advertisers.

Feed news

FXStreet Trading Signals now available!

Access to real-time signals, community and guidance now!

Latest Forex News

Latest Forex News

Editors’ Picks

EUR/USD recovers towards 1.1750 as risk-on rules

EUR/USD is back around 1.1750 as upbeat US data fueled equities' early rally. Concerns about economic progress remain in the background, as the pandemic keeps taking its toll. 


GBP/USD bounces from 1.30 as demand for the dollar eases

Dollar's corrective advance seems complete, now down against most major rivals. GBP/USD trades little changed for a second consecutive day in the 1.3060/70 price zone. Market players continue to ignore upcoming Brexit chaos.


Gold: Interesting Fibonacci extension projects a move to $2500

Gold has risen 10.74% in the month of July, the biggest monthly increase since February 2016. As the price is breaking all-time highs it's hard to say where the yellow metal could end up.

Gold News

ETH/BTC skyrocketing, Bitcoin stays above $11,000

The cryptocurrency market is influenced by leveraged positions liquidation. Cryptocurrency experts expect further growth amid a global flight to safety assets. ETH/BTC hits the highest level since May 2019.

Read more

WTI drops below $40 on demand worries, OPEC+ output increase

Crude oil prices posted losses last week and seem to be struggling to shake off the bearish pressure on Monday. As of writing, the barrel of West Texas Intermediate (WTI) was trading at $39.85, losing 1.5% on a daily basis.

Oil News